carbenicillin has been researched along with ciprofloxacin in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 12 (40.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, P; Hudock, MP; Leon, A; Liu, L; Morita, CT; Oldfield, E; Puan, KJ; Studer, D; Yang, Y; Yin, F | 1 |
| Kwon, DH; Lu, CD | 1 |
| Bhattacharjee, G; Kumar, A; Tomar, V | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barrow, K; Kwon, DH | 1 |
| Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
| Mima, T; Schweizer, HP | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Douboyas, JP; Sofianou, DC | 1 |
| Chin, NX; Jules, K; Neu, HC | 1 |
| Costa, MA; Martins, CA; Nucci, M; Velasco, E | 1 |
| Ciofu, O; Giwercman, B; Høiby, N; Pedersen, SS | 1 |
| Richards, RM; Xing, JZ | 1 |
| Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
| Blondeau, JM; Borsos, S; Misfeldt, C; Suter, ME | 1 |
| Estahbanati, HK; Ghanaatpisheh, F; Kashani, PP | 1 |
| Church, GM; Dantas, G; Oluwasegun, RD; Sommer, MO | 1 |
| Dean, CR; Möker, N; Tao, J | 1 |
| Bahar, AA; Pan, J; Ren, D; Syed, H | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Abdelbacki, AMM; El-Gebaly, RH; Fadel, MA; Mohamed, SA | 1 |
| Bai, F; Cheng, Z; Dong, Y; Fan, Z; Jin, S; Jin, Y; Pan, X; Ren, H; Wu, W; Xu, C | 1 |
| Cheng, Z; Cohen, A; Daboor, SM; Raudonis, R; Rohde, JR | 1 |
| Badran, AH; Bening, SC; Cheney, NJ; Collins, JJ; Earl, AM; Kohanski, MA; Lopatkin, AJ; Manson, AL; Stokes, JM; Yang, JH | 1 |
1 review(s) available for carbenicillin and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for carbenicillin and ciprofloxacin
| Article | Year |
|---|---|
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillin V; Prospective Studies | 1995 |
28 other study(ies) available for carbenicillin and ciprofloxacin
| Article | Year |
|---|---|
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Topics: Anti-Bacterial Agents; Cluster Analysis; Diphosphonates; Drug Synergism; Escherichia coli K12; Fosfomycin; Gene Expression; Geranyltranstransferase; Models, Molecular; Oligonucleotide Array Sequence Analysis; Quantitative Structure-Activity Relationship; Terpenes | 2006 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzaldehydes; Candida; Candida albicans; Chalcones; Ciprofloxacin; Escherichia coli; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Piperazines; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa | 1991 |
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Topics: Animals; Azlocillin; Bacteria; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Humans; Listeria monocytogenes; Male; Mice; Neisseriaceae; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Staphylococcus aureus; Streptococcus; Ticarcillin | 1986 |
Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Denmark; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1994 |
Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
Topics: Anti-Bacterial Agents; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Enzyme Inhibitors; Evaluation Studies as Topic; Folic Acid Antagonists; Gentamicins; Microbial Sensitivity Tests; Rifampin; Trimethoprim | 1996 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Carbenicillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Geography; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections | 1998 |
Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics.
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Burns; Carbenicillin; Ceftazidime; Ceftizoxime; Cephalothin; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Male; Middle Aged; Pseudomonas aeruginosa; Serotyping; Staphylococcus aureus; Tetracycline; Wound Infection | 2002 |
Bacteria subsisting on antibiotics.
Topics: Actinobacteria; Anti-Bacterial Agents; Bacteroidetes; Carbenicillin; Ciprofloxacin; Drug Resistance, Bacterial; Molecular Sequence Data; Penicillins; Phylogeny; Proteobacteria; Soil Microbiology | 2008 |
Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules.
Topics: Acyl-Butyrolactones; Anti-Bacterial Agents; Bacterial Proteins; Carbenicillin; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Gene Deletion; Genetic Complementation Test; Humans; Microbial Viability; Paraquat; Pseudomonas aeruginosa; Pyocyanine; Quorum Sensing; Signal Transduction; Stress, Physiological | 2010 |
Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one.
Topics: 4-Butyrolactone; Analysis of Variance; Anti-Bacterial Agents; Biofilms; Carbenicillin; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Genes, Bacterial; Gentamicins; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Pseudomonas aeruginosa; Quorum Sensing; Tetracycline; Tobramycin; Transcriptome | 2012 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Biophysical control of the growth of Agrobacterium tumefaciens using extremely low frequency electromagnetic waves at resonance frequency.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefaclor; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Electromagnetic Radiation; Fluoroquinolones; Gatifloxacin; Gentamicins; Plant Tumors; Rifampin; Solanum lycopersicum | 2017 |
Mechanisms of RsaL mediated tolerance to ciprofloxacin and carbenicillin in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbenicillin; Ciprofloxacin; Drug Tolerance; Gene Expression Regulation, Bacterial; Mutation; Operon; Pseudomonas aeruginosa; Quorum Sensing; Repressor Proteins; Signal Transduction; Trans-Activators | 2019 |
Marine Bacteria, A Source for Alginolytic Enzyme to Disrupt
Topics: Alginates; Anti-Bacterial Agents; Aquatic Organisms; Biofilms; Carbenicillin; Ciprofloxacin; Polysaccharide-Lyases; Pseudoalteromonas; Pseudomonas aeruginosa; RNA, Ribosomal, 16S | 2019 |
Clinically relevant mutations in core metabolic genes confer antibiotic resistance.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Carbenicillin; Ciprofloxacin; Citric Acid Cycle; Directed Molecular Evolution; Drug Resistance, Bacterial; Energy Metabolism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Knockdown Techniques; Genes, Bacterial; Genome, Bacterial; Ketoglutarate Dehydrogenase Complex; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Streptomycin | 2021 |